Does CANAGLIFLOZIN Cause Respiratory failure? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Respiratory failure have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.2% of all adverse event reports for CANAGLIFLOZIN.
58
Reports of Respiratory failure with CANAGLIFLOZIN
0.2%
of all CANAGLIFLOZIN reports
10
Deaths
55
Hospitalizations
How Dangerous Is Respiratory failure From CANAGLIFLOZIN?
Of the 58 reports, 10 (17.2%) resulted in death, 55 (94.8%) required hospitalization, and 21 (36.2%) were considered life-threatening.
Is Respiratory failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does CANAGLIFLOZIN Cause?
Diabetic ketoacidosis (3,413)
Toe amputation (2,193)
Osteomyelitis (2,146)
Acute kidney injury (1,853)
Fungal infection (1,385)
Gangrene (1,081)
Weight decreased (1,014)
Cellulitis (1,007)
Urinary tract infection (920)
Diabetic foot infection (832)
What Other Drugs Cause Respiratory failure?
PREDNISONE (2,299)
CYCLOPHOSPHAMIDE (2,096)
RITUXIMAB (1,838)
TACROLIMUS (1,758)
METHOTREXATE (1,685)
DEXAMETHASONE (1,603)
MYCOPHENOLATE MOFETIL (1,469)
METHYLPREDNISOLONE (1,442)
PREDNISOLONE (1,346)
VINCRISTINE (1,120)
Which CANAGLIFLOZIN Alternatives Have Lower Respiratory failure Risk?
CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN
CANAGLIFLOZIN vs CANAKINUMAB
CANAGLIFLOZIN vs CANDESARTAN
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL
CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE